Qingyuan Tuowei Anchuang Technology Development

Qingyuan Tuowei Anchuang Technology Development is a biotechnology company specializing in the development and industrialization of exosome-based therapeutic delivery systems. The company leverages a proprietary engineering platform to load exosomes with various therapeutic payloads, including small molecules and nucleic acids, to achieve targeted delivery and reduced systemic toxicity. Based in the Qingyuan High-tech Zone in Guangdong, the firm operates as a critical manufacturing and scale-up hub for the broader Tuowei Anchuang group. Their research pipeline primarily focuses on high-unmet-need areas such as oncology and chronic inflammatory disorders. By integrating advanced bioengineering with pilot-scale production capabilities, the company aims to accelerate the clinical translation of next-generation exosome medicines.